Institutions

Learn more about the importance of medical coding dictionaries, their common uses, and best practices.

Coercion and undue influence in research can be complicated. Understand what these terms mean and how to appropriately protect against them.

Our experts answered some of the most popular questions from "Racial Diversity in Clinical Trials: Building Trust in Participant Engagement."

Checking the box is still an option on the FWA. At this time, institutions must carefully consider whether it makes sense to check the box.

On October 22, 2020, the FDA's VRBPAC met to discuss the development, authorization, and licensure of vaccines to prevent COVID-19.

Daniel Eisenman answers questions from his latest webinar Study Startup Success for the New Generation of Genetically Engineered Vaccines.

In investigator-initiated trials, an investigator takes on the clinical study as both the sponsor and investigator. Learn more about IITs impact on the clinical research industry.

New California regulations apply to companies who have information about CA residents regardless of where the company is located. Read more:

How has the COVID-19 pandemic changed oncology research--and research in general? Read more for the follow-up blog to our recent symposium:

Learn more about how you can improve your clinical research data quality with these five fundamentals of clinical data management.

When using remote sites to perform clinical trial procedures, keep in mind things like whether remote sites are considered "engaged" in research. Read more:

COVID-19 complicates traditional models of community consultation. How should sites conducting planned emergency research approach community consultation?